BACH BOLIGCENTER ApS: Financial statements 2017
CVR: 12024584
Source: annual report 2017, Danish Business Authority
01/05/2016 – 30/04/2017
BACH BOLIGCENTER ApS (CVR 12024584) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -13,058 and a net result of DKK 78,304 compared with DKK -47,638 the year before. Equity in the 2017 report amounted to DKK 1,260,410. The solvency ratio was 99.2%.
- Gross Profit
- DKK -13,058
- Profit/Loss
- DKK 78,304
- Equity
- DKK 1,260,410
- Total Assets
- DKK 1,270,410
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -13K | 78K | 1.3M | - |
| 2016 | - | -13K | -48K | 1.2M | - |
| 2015 | - | -14K | 234K | 1.8M | - |
| 2014 | - | -13K | 21K | 1.6M | - |
| 2013 | - | -12K | 89K | 1.6M | - |
Official annual report
Keep an eye on BACH BOLIGCENTER ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of June 15, 2017, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has stepped down as auditor of BACH BOLIGCENTER ApS.
About BACH BOLIGCENTER ApS
BACH BOLIGCENTER ApS is a Danish company of the type Anpartsselskab based in Hammel, founded in 1988. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named EMBRYODAN ApS. The management consists of Geo Koch. The company is owned by Geo Koch. The company has 1 employee (2023). In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122.